BioSpace News Archive

Press Releases

Cantargia Presents Association Between Nadunolimab and Reduction of Chemotherapy Induced Peripheral Neuropathy (CIPN) at AACR

April 28, 2025
·
5 min read
Press Releases

Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

April 28, 2025
·
9 min read
Press Releases

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System

April 28, 2025
·
3 min read
Press Releases

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 25, 2025

April 28, 2025
·
2 min read
Press Releases

Prelude Announces Presentations at 2025 AACR Annual Meeting

April 28, 2025
·
7 min read
Press Releases

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 25, 2025

April 28, 2025
·
3 min read
Press Releases

UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

April 28, 2025
·
8 min read
Press Releases

Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC

April 28, 2025
·
10 min read
Press Releases

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

April 28, 2025
·
3 min read
Press Releases

Johnson & Johnson’s TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer

April 28, 2025
·
9 min read